Rechercher une ressource pédagogique : biomarker

Le moteur de recherche des ressources pédagogiques donne accès à un ensemble de documents mis à disposition par l'Université Numérique, les établissements d'enseignement supérieur et Canal U. Vous y trouverez des productions universitaires dans l'ensemble des domaines de formation.

FILTRES

9 résultats
section 1 sur 1
résultats 1 à 9
Canal-U
Canal-U
28.11.2014
EN-6. Biomonitoring
Description : Stellio Casas presents the biomonitoring. This tool of biodiversity management can be used for the different biological levels of the life. It leads to the identification of bioaccumulators, biomarkers and biodiversity indications.
  • biodiversity
  • bioindicator
  • biomonitoring
  • bioaccumulator
  • biomarker
  • biodiversity indication
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker Speaker: Stefan BLANKENBERG, Hamburg, GER Discussant: Nancy GELLER, Bethesda, USA Abstract : Best statistical methods for evaluating the merits of a novel ma ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker Speaker: Stefan BLANKENBERG, Hamburg, GER Discussant: Nancy GELLER, Bethesda, USA Abstract : Best statistical methods for evaluating the merits of a novel ma ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Biomarker guided-therapy: Are there other endpoints besides mortality that matter? Selecting the best outcome measures
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Biomarker guided-therapy: Are there other endpoints besides mortality that matter? Selecting the best outcome measures Speaker: Michael FELKER, Durham, USA Abstract : Biomarker guided-therapy: Are there other endpoints besides ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : debate : Best statistical methods for evaluating the merits of a novel marker (debates).
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : debate : Best statistical methods for evaluating the merits of a novel marker (debates). Speaker: Stefan BLANKENBERG, Hamburg, GER Discussant: Nancy GELLER, Bethesda, USA Abstract : debate : Best statistical methods for evaluating ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies? John JARCHO, Boston, USA, NEJM Rita REDBERG, San Francisco, ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies? John JARCHO, Boston, USA, NEJM Rita REDBERG, San Francisco, ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied? Speaker: Jim JANUZZI, Boston, USA Discussant: James SNIDER, Critical Diagnostics, USA Abstract : How should Diagnostic and Prognostic Markers Be Studied? The measurement of ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Canal-U
Canal-U
01.12.2012
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied? Speaker: Jim JANUZZI, Boston, USA Discussant: James SNIDER, Critical Diagnostics, USA Abstract : How should Diagnostic and Prognostic Markers Be Studied? The measurement of ...
  • Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker